CareDx (CDNA) Preferred Stock Liabilities (2013 - 2014)
CareDx's (CDNA) quarterly Preferred Stock Liabilities came in at $149.4 million in Q2 2014, up 10.53% quarter-over-quarter from $135.2 million in Q4 2013.
Powered by 
Analysis
CareDx (CDNA) Preferred Stock Liabilities (2013 - 2014) Analysis & Trends
CareDx has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $149.4 million for Q2 2014.
- In Q2 2014, Preferred Stock Liabilities changed N/A year-over-year to $149.4 million; the TTM figure through Jun 2014 stood at $149.4 million (changed N/A YoY), while the FY2013 annual figure was $135.2 million, changed N/A from the prior year.
- Preferred Stock Liabilities came in at $149.4 million for Q2 2014 at CareDx, up from $135.2 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $149.4 million in Q2 2014 to a low of $135.2 million in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | - |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | - |
| 10 | CareDx | 2.77 Bn | 2.40 Bn | 116.03 Mn | - |